155 related articles for article (PubMed ID: 10922227)
21. [In vitro gene silencing by siRNA of cyclin D1 on tongue squamous cell carcinoma cell line resistant to cisplatin].
Zhou XJ; Zhang ZY; Zhang P; Pan HY; Chen WT; Ye DX
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov; 41(11):646-9. PubMed ID: 17331354
[TBL] [Abstract][Full Text] [Related]
22. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
[TBL] [Abstract][Full Text] [Related]
23. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo.
Zhu L; Luo Q; Bi J; Ding J; Ge S; Chen F
Chem Biol Interact; 2014 Dec; 224():149-56. PubMed ID: 25450235
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma.
Gioacchini FM; Alicandri-Ciufelli M; Kaleci S; Magliulo G; Presutti L; Re M
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):801-9. PubMed ID: 25516222
[TBL] [Abstract][Full Text] [Related]
25. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
[TBL] [Abstract][Full Text] [Related]
26. In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
Xi S; Gooding WE; Grandis JR
Oncogene; 2005 Feb; 24(6):970-9. PubMed ID: 15592503
[TBL] [Abstract][Full Text] [Related]
27. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
28. Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model.
Lee TK; Poon RT; Wo JY; Ma S; Guan XY; Myers JN; Altevogt P; Yuen AP
Cancer Res; 2007 Sep; 67(18):8800-9. PubMed ID: 17875721
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.
Liu Y; Yu C; Qiu Y; Huang D; Zhou X; Zhang X; Tian Y
J Cancer Res Clin Oncol; 2012 Feb; 138(2):195-202. PubMed ID: 22086185
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-conjugating enzyme UBE2Q2 suppresses cell proliferation and is down-regulated in recurrent head and neck cancer.
Maeda H; Miyajima N; Kano S; Tsukiyama T; Okumura F; Fukuda S; Hatakeyama S
Mol Cancer Res; 2009 Sep; 7(9):1553-62. PubMed ID: 19723876
[TBL] [Abstract][Full Text] [Related]
31. Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1 alone or combined with cisplatin.
Oridate N; Kim HJ; Xu X; Lotan R
Cancer Biol Ther; 2005 Mar; 4(3):318-23. PubMed ID: 15846092
[TBL] [Abstract][Full Text] [Related]
32. Ethanol decreases negative cell-cycle-regulating proteins in a head and neck squamous cell carcinoma cell line.
Kornfehl J; Hager G; Gedlicka C; Formanek M
Acta Otolaryngol; 2002 Apr; 122(3):338-42. PubMed ID: 12030586
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity.
Zhou X; Zhang Z; Yang X; Chen W; Zhang P
Int J Cancer; 2009 Jan; 124(2):483-9. PubMed ID: 18942709
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 antisense oligodexoyneucleotides inhibits growth and enhances chemosensitivity in gastric carcinoma cells.
Shuai XM; Han GX; Wang GB; Chen JH
World J Gastroenterol; 2006 Mar; 12(11):1766-9. PubMed ID: 16586549
[TBL] [Abstract][Full Text] [Related]
35. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
[TBL] [Abstract][Full Text] [Related]
36. Curcumin suppresses growth of head and neck squamous cell carcinoma.
LoTempio MM; Veena MS; Steele HL; Ramamurthy B; Ramalingam TS; Cohen AN; Chakrabarti R; Srivatsan ES; Wang MB
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6994-7002. PubMed ID: 16203793
[TBL] [Abstract][Full Text] [Related]
37. Role of squamous cell carcinoma antigen 1 expression in the invasive potential of head and neck squamous cell carcinoma.
Nakashima T; Yasumatsu R; Kuratomi Y; Masuda M; Kuwano T; Toh S; Umezaki T; Cataltepe S; Silverman GA; Komune S
Head Neck; 2006 Jan; 28(1):24-30. PubMed ID: 16155915
[TBL] [Abstract][Full Text] [Related]
38. miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.
Jiang S; Zhao C; Yang X; Li X; Pan Q; Huang H; Wen X; Shan H; Li Q; Du Y; Zhao Y
Int J Mol Med; 2016 Jul; 38(1):113-22. PubMed ID: 27247259
[TBL] [Abstract][Full Text] [Related]
39. KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma.
Jiffar T; Yilmaz T; Lee J; Hanna E; El-Naggar A; Yu D; Myers JN; Kupferman ME
Oncogene; 2011 Jul; 30(28):3163-73. PubMed ID: 21383688
[TBL] [Abstract][Full Text] [Related]
40. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
